Show simple item record

AuthorZenz, Thorstendc.contributor.author
AuthorGribben, John G.dc.contributor.author
AuthorHallek, Michaeldc.contributor.author
AuthorDöhner, Hartmutdc.contributor.author
AuthorKeating, Michael J.dc.contributor.author
AuthorStilgenbauer, Stephandc.contributor.author
Date of accession2018-01-15T14:14:03Zdc.date.accessioned
Available in OPARU since2018-01-15T14:14:03Zdc.date.available
Date of first publication2012dc.date.issued
Languageendc.language.iso
PublisherUniversität Ulmdc.publisher
Keywordchronic lymphocytic-leukemiadc.subject
Keywordfludarabine plus cyclophosphamidedc.subject
Keywordstem-cell transplantationdc.subject
Keywordphase-3 trialdc.subject
Keywordsponsored-working-groupdc.subject
Keywordindependent predictordc.subject
Keyword1st-line therapydc.subject
Keywordinitial therapydc.subject
Keywordtp53 mutationdc.subject
Keyword17p deletiondc.subject
Dewey Decimal GroupDDC 610 / Medicine & healthdc.subject.ddc
TitleRisk categories and refractory CLL in the era of chemoimmunotherapydc.title
Resource typeWissenschaftlicher Artikeldc.type
InstitutionUKU. Klinik für Innere Medizin IIIuulm.affiliationSpecific
DCMI TypeTextuulm.typeDCMI
CategoryPublikationsnachweiseuulm.category
DOI (external)10.1182/blood-2011-11-312421dc.identifier.doiExternal
Source - Title of sourceBloodsource.title
Source - Place of publicationAmerican Society of Hematologysource.publisher
Source - Volume119source.volume
Source - Issue18source.issue
Source - Year2012source.year
Source - From page4101source.fromPage
Source - To page4107source.toPage
Source - ISSN0006-4971source.identifier.issn
Open AccessNouulm.OA
CommunityUniversitätsklinikum Ulmuulm.community
WoS000305284600005uulm.identifier.wos
Bibliographyuulmuulm.bibliographie


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record